https://atamparibinhibitor.com..../azimuthal-rotation-
Change in the 24-hour cough count from baseline, after 12 weeks of intervention, defined the principal endpoint. Randomization of 310 participants led to four treatment groups: twice-daily eliapixant 25mg (n=75), 75mg (n=78), 150mg (n=8, and placebo (n=77). Analysis revealed a statistically significant dose-response relationship for eliapixant concerning the primary endpoint across all dose-response models (adjusted p0.01, one-tailed). Among those given a placebo, 39 participants (r
Respect!
Kommentar
Delen
